Cytovale, Inc.

Cytovale is a medical diagnostics company headquartered in South San Francisco, specializing in rapid sepsis detection and immune-mediated disease diagnostics. The company's flagship product, IntelliSep®, is an FDA-cleared in vitro diagnostic test that delivers sepsis risk stratification results in approximately 8 minutes from a standard blood draw. IntelliSep analyzes the biomechanical properties of white blood cells to assess immune activation and predict the probability of sepsis with organ dysfunction within 3 days of testing. Designed for emergency departments, IntelliSep enables rapid patient triage, reduces unnecessary antibiotic use and blood cultures, shortens length of stay, and improves operational throughput. The company's deformability cytometry platform represents a significant advancement in rapid infectious disease diagnostics, addressing a critical gap in sepsis detection where earlier treatment initiation directly correlates with improved patient survival outcomes.